Latest News
Alectinib and dacomitinib show potential in separate trials for lung cancer
ArQule begins dosing of ARQ 092 in Phase I/II trial for overgrowth diseases
US-based biopharmaceutical firm ArQule has begun dosing patients with ARQ 092 in a Phase I/II clinical trial to treat patients with rare overgrowth...
Psoriasis drug demonstrates positive outcome in two Phase III trials
A biologic agent known as tildrakizumab has demonstrated a positive outcome in two Phase III trials conducted by Harvard Medical School’s Beth Israel Deaconess Medical Centre (BIDMC) in the US...
Janssen reports positive follow-up data from Phase III trial of Imbruvica for CLL
Janssen-Cilag International (Janssen) has reported positive data from a four-year follow-up period of its Phase III RESONATE trial of Imbruvica (ibrutinib) to treat relapsed / refractory...
New Phase I/II trial of MV-CHIKV for chikungunya begins enrolment
Prostate cancer trial shows improved survivability with additional hormone therapy
MorphoSys initiates Phase III trial of MOR208 and bendamustine for DLBCL
German biotechnology firm MorphoSys has initiated patient enrolment for the Phase III part of the Phase II/III B-MIND clinical trial of MOR208 and bendamustine combination to treat diffuse...
New ovarian cancer drug found to shrink tumours in women
Janssen reports positive results from two Phase III combination trials of Darzalex
Janssen Research & Development has reported positive results from the updated Phase III CASTOR and POLLUX clinical trials of Darzalex (daratumumab) combined with bortezomib and dexamethasone...
Ocera doses first patient in Phase IIa trial of OCR-002 to treat cirrhosis
AstraZeneca’s Lynparza shows positive outcome in Phase III trial for ovarian cancer
AstraZeneca has reported positive findings from the Phase III SOLO-2 clinical trial of Lynparza (olaparib) to treat patients with germline BRCA-mutated (gBRCAm), platinum-sensitive, relapsed...
Seattle Genetics and BMS to study Adcetris in Phase III combination trial to treat HL
Seattle Genetics has partnered with Bristol-Myers Squibb (BMS) to study the combination of Adcetris (brentuximab vedotin) with Opdivo in a Phase III clinical trial for the treatment of...
Inovio to assess new T-cell therapy in Phase Ib/II combination trial for bladder cancer
Vaxon reports positive data from Phase IIb trial of Vx-001 to treat NSCLC
French biopharmaceutical firm Vaxon Biotech has reported positive findings from the Phase IIb clinical trial of Vx-001 for the treatment of patients with non-small-cell lung cancer...
Alzheimer’s drug candidate shows positive outcome in Phase II trial for Down syndrome
A Phase II clinical trial conducted at the Massachusetts General Hospital in the US to evaluate scyllo-inositol (ELND005) for the treatment of young adults with Down syndrome has demonstrated...
New Phase I trial investigates targeted molecular therapy to treat prostate cancer in US
Cingulate begins dosing healthy subjects in Phase I trial of CTX-1301 to treat ADHD
US-based biopharmaceutical firm Cingulate Therapeutics has begun dosing healthy volunteers in the Phase I proof-of-concept trial of its product candidate...
Array BioPharma and BMS to assess cancer drugs in Phase I/II combination trial
Array BioPharma has entered a strategic clinical research collaboration with Bristol-Myers Squibb (BMS) to evaluate the combination of binimetinib with Opdivo (nivolumab) and Opdivo +...
Researchers discover new enzyme to aid Parkinson’s treatment
Imcyse to initiate Phase Ib trial of Imotopes to treat type 1 diabetes
Immunotherapeutic vaccines developer Imcyse is set to initiate the Phase Ib clinical trial of Imotopes for the treatment of insulin-dependent (type 1) diabetes, following the authorisation from...
Gilead reports positive data from four Phase III combination trials for HIV-1
US-based biopharmaceutical firm Gilead Sciences has reported positive results from four Phase III clinical trials investigating the combination of bictegravir (BIC), emtricitabine (FTC)...
